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Large bone defects and nonunions are serious complications that are caused by extensive trauma or tumour. As traditional therapies
fail to repair these critical-sized defects, tissue engineering scaffolds can be used to regenerate the damaged tissue. Highly porous
titanium scaffolds, produced by selective laser sintering with mechanical properties in range of trabecular bone (compressive
strength 35MPa and modulus 73MPa), can be used in these orthopaedic applications, if a stable mechanical fixation is provided.
Hydroxyapatite coatings are generally considered essential and/or beneficial for bone formation; however, debonding of the coatings
is one of the main concerns. We hypothesised that the titanium scaffolds have an intrinsic potential to induce bone formation
without the need for a hydroxyapatite coating. In this paper, titanium scaffolds coated with hydroxyapatite using electrochemical
method were fabricated and osteoinductivity of coated and noncoated scaffolds was compared in vitro. Alizarin Red quantification
confirmed osteogenesis independent of coating. Bone formation and ingrowth into the titanium scaffolds were evaluated in sheep
stifle joints. The examinations after 3 months revealed 70% bone ingrowth into the scaffold confirming its osteoinductive capacity.
It is shown that the developed titanium scaffold has an intrinsic capacity for bone formation and is a suitable scaffold for bone tissue
engineering.
1. Introduction
Massive traumatic injuries or tumour resections are among
the factors which can contribute to substantial bone loss [1, 2].
Thanks to a spontaneous capacity for regeneration,most bone
lesions, such as fractures, can be repaired with conventional
therapies. The process of fracture healing is a sequence that
begins with hematoma formation and then moves to inflam-
mation, destruction of nonvital debris, granulation tissue
proliferation, callus formation, conversion of woven bone to
lamellar bone, and, finally, remodelling of the healed bone [3].
However, in cases of large defects and osseous congenital
deformities, bone grafts (e.g., xeno-, allo-, and autografts) or
substitutes are needed to aid healing [4]. The current gold
standard for repair of large bone defects [1] is autograft where
host bone is removed from another non-load-bearing site
to fill the defect. However, the complication rate is as high
as 30% due to donor site morbidity, pain, hematoma, and
inflammation. Inmany cases, this has been proven a challeng-
ing treatment for critical-sized defects [1].
Tissue engineering (TE) approaches, which use body’s
natural ability to repair injured bone with new bone tissue
and to remodel newly produced bone in response to the
local stresses, are being explored as alternatives for large bone
defect repairs [5].There are three key ingredients necessary in
TE: a scaffold, which may be either natural or synthetic, cells
[6], and inductive signals (i.e., growth factors or proteins) [7].
Studies have suggested that cells might be unable to
establish themselves properly within a defect without matrix
guidance [8]. Therefore, a scaffold must be developed to
provide a three-dimensional structure to support the cells,
aid their proliferation, and help them be differentiated, while
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its architecture defines the ultimate shape of the new bone
[9, 10].
In addition to general requirements for TE scaffolds
such as biocompatibility and ability to be sterilised, the key
requirements for the development of an orthopaedic scaffold
include the following [1]:
(1) Mechanical stability to be retained in the affected area
(2) Interconnected porous architecture (porosity exceed-
ing 90%) [4, 11] to allow for vascularization and bone
ingrowth and to act as a channel for delivery of
nutrients and gases to the cells deep inside the scaffold
and, at the same time, removal of the metabolic waste
from cells
(3) Supporting and promoting osteogenic differentiation
of undifferentiated cells (osteoinduction) and growth
of differentiated bone cells (osteoconduction) [12]
(4) Enhancing cellular activity towards scaffold-host tis-
sue integration (osseointegration).
Mechanical properties are especially important in scaf-
folds for hard and ductile tissues such as bone [13, 14]
because the scaffolds must also interact with their physio-
logical surroundings to transmit mechanical signals to cells
and regulate cell behaviour (i.e., differentiation, motility,
and contractility). The stiffness of scaffold can have effects
at a transcriptional level, determining whether stem cells
make the decision to become cells as functionally diverse as
osteoblasts [15].
Biomaterials used in tissue engineering of bone are
usually categorized into fourmajor groups: natural polymers,
synthetic polymers, metallic materials, and inorganic materi-
als such as ceramics and bioactive glasses. Multicomponent
systems can be designed to generate composites of enhanced
performance [16].
Naturally derived polymers have the advantage of native
biological function [17, 18] but their low mechanical strength
makes them less attractive as an option for bone tissue repair.
In synthetic polymers, on the other hand, it is possible to
precisely control the mechanical properties; however, they
exhibit poor cell adhesion [18]. Bioceramics are known to
enhance and promote biomineralization [14, 16], but their
brittleness and low fracture toughness means that they are
mostly suitable only in combination with other materials and
in form of composites.
Metallic scaffolds are promising alternatives for hard
load-bearing tissue repairs. These biomaterials in their solid
form have been widely used for fabrication of the implants
replacing hard human tissues for many years [19], and
therefore in their porous form they can be possible candidates
for TE approaches. Titanium and its alloys are of great
interest in biomedical applications due to their excellent
combinations ofmechanical properties, biocompatibility, and
chemical stability [20] and one of their drawbacks, which
is the mismatch of mechanical properties between bulk
titanium and natural bone which leads to stress shielding,
and eventual implant loosening, that can be rectified by
producing a low modulus porous network [21, 22]. In fact, Ti
meshes have been successfully used in spine fusion surgeries
and for oral and maxillofacial structures [23]. Introduction
of porosity and pore interconnectivity improves mechanical
fixation and osteointegration by allowing extensive body fluid
transport through the porous implant.This can provoke bone
tissue ingrowth, consequently leading to the development of
a stable interface between the scaffold and host tissue [19].
The porous Timatrices can be produced using techniques
such as powder metallurgy (PM) [19, 22] or additive manu-
facturing technique (AM) [20, 24]. The drawbacks of the PM
including limited control over the size, shape, and distribu-
tion of the porosity [25] can be resolved usingAMtechniques.
Selective laser melting (SLM) and Selective Laser Sintering
(SLS) are two of the AM processes that are able to produce
complex structures layer by layer with high precision. Where
SLS uses a very precise nanolaser beam to sinter the powder
material to build up the structure [24], SLM fully melts the
powder to form a solid mass. Direct metal laser sintering
(DMLS) is essentially similar to SLS in terms of method, as
it involves sintering rather than melting, but where SLS is
used for polymers, ceramics as well as metals, DMLS is used
exclusively for metals. With DMLS it is possible to control
the porosity of each layer, pore interconnectivity, size, shape,
and distribution, and consequently the 3D architecture of
the implant, by changing the processing parameters, such as
laser power, laser spot diameter, and layer thickness, or by
modifying the size of the original titanium particles [26, 27].
Titanium is considered a bioinert material, which does
not possess osteoconductivity or osteoinductivity by itself;
however, the surface can bemodified to induce osteoconduc-
tivity [28] or osteoinductivity [29]; hydroxyapatite (HAp) is
a very good biomaterial which has excellent osteoinductivity
and has been widely used in bone defect repairs. HAp
coatings can be used to prompt osteogenesis without the need
for additional osteogenic cells or bone morphogenic proteins
(BMP) [28]. Conventional HAp coating of solid titanium
surfaces involves plasma spraying which is a line of sight
technique and fails to coat inner surfaces of porous structures.
HAp coatings can be produced using techniques such as
electrochemical deposition and biomimetic method. Both
methods are based on precipitation from aqueous solutions,
take place at low temperature, are economical, and allow
coating of complex shapes. The biomimetic method uses
simulated body fluids (SBF) that mimic physiological ionic
strength and pH. In a typical electrochemical deposition, a
precursor (brushite) is first formed that is converted into
hydroxyapatite (HA) through an ageing process. Thus this
method offers a control over crystallinity [30]. However,
debonding and loss of HAp coatings in vivo are one of the
main concerns in using these coatings [31, 32].
In this study, we have produced a porous titanium scaffold
for bone tissue engineering using SLS technique. We have
used both electrochemical and biomimetic processes to coat
the three-dimensional Ti matrix with hydroxyapatite and
compared the osteoinductivity of coated and noncoated
scaffolds in vitro. Electrochemical deposition leads to a more
uniform coating and was used as the main coating method
for any further analysis. Our results showed that interestingly
HAp coating did not significantly increase osteogenecity
(Alizarin Red production) in vitro and noncoated Ti scaffolds
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Table 1: Composition of SBF coating solutions.
NaCl NaHCO
3
K
2
HPO
4
⋅3H
2
O MgCL
2
⋅6H
2
O CaCl
2
⋅2H
2
O
Solution A 680mM 21mM 5mM 7.6mM 9.9mM
Solution B 680mM 10mM 5mM 1.5mM 9.9mM
Table 2: Scaffold formulations in terms of coating technique and conditions.
Coating method Condition Acronym
Biomimetic method
Solution A (hrs) Solution B (hrs)
24 48 BM24
48 48 BM48
Electrochemical method Current density (mA/cm
2)
6 10 EM6 and EM10
were also osteoinductive.These scaffoldswere then implanted
in sheep femoral condyle to investigate bone formation
and ingrowth. Extensive osteoinduction and osteointegration
(70% bone ingrowth) were observed in vivo, confirming the
intrinsic capacity of the produced porousTi scaffolds for bone
regeneration.
2. Materials and Methods
2.1. Fabrication of Ti Matrix. Titanium lattices were fab-
ricated from commercially pure titanium powder (cp-Ti)
using a DMLS system (EO SINTM270). Cp-Ti and titanium
alloys (typically Ti6Al4V) are used extensively as dental
and orthopaedic implants, respectively. Alloying improves
the mechanical properties of titanium for use in high load-
bearing applications; however, some concerns related to the
toxicity of various alloying elements do exist [33]. Since no
significant differences were observed in terms of osseointe-
gration, biomechanical anchorage, and bacterial interaction
between cp-Ti and Ti alloys [33], we selected cp-Ti (grade
4, 99% purity, density 4.51 g/cm3, and Young’s modulus of
105GPa) in this study to avoid this concern.
A 200W Yb fiber laser was used to sinter Ti powder. The
scaffold was built at a speed of 4mm2/s with layer thickness
of 40 𝜇m, resulting in a cylindrical scaffold (10mm × 8mm)
with strut thickness of 1.5mm, pitch size of 0.75mm, and
porosity of 72%.
Prior to coating, the scaffolds were ultrasonically cleaned
in 10% Decon90 (Decon Laboratory Limited, UK), distilled
water, and ethanol for 15mins each, and dried in air.
2.2. HAp Coating Deposition and Characterisation. Two
methods forHAp coating of porous Timatrix were employed:
biomimetic coating process and electrochemical deposition.
In the biomimetic coating procedure, saturated simulated
body fluid (5x SBF) was used according to a previously
published method [30]. Briefly, coating solutions A and B
were prepared (Table 1) by dissolving reagent grade salts
(Sigma-Aldrich, UK) at 37∘C with a constant 5% CO
2
supply
and stirring in distilled water. Samples were firstly soaked in
solution A, for 24 or 48 hrs at 37∘C and then in solution B for
48 hrs at 40∘C with constant stirring.
In the electrochemical method, titanium lattices were
immersed in the CaP solution (0.13M, Ca(H
2
PO
4
)
2
, Sigma-
Aldrich, UK) and attached to the negative terminal of a DC
Dual Power Supply pack (Peak Tech, Telonic Instruments
Ltd, UK). Two different electrical current densities of 10
and 6mA/cm2 were applied between the two electrodes
for 10mins. The samples were then soaked in 0.1M NaOH
solution for 72 h, cleaned in distilled water, and air-dried.
Scaffold formulations are summarized in Table 2.
Morphology of deposited HAp was observed by scanning
electron microscopy (SEM, JEOL JSM 5500 LV, at 10 kV) and
elemental analysis was performed by energy dispersive X-ray
spectroscopy (EDAX, EDAX Inc., USA).
2.3. Evaluation of Mechanical Properties and In VitroMechan-
ical Stability. The mechanical properties of the structures
were determined in a universal material testing machine
(Instron 5565) under uniaxial compressive load. Ti scaffolds
(𝑛 = 3) were placed between two hard metal compression
inserts. The force and deformation were recorded during the
strain-controlled compression phase with a constant strain of
1mm/min at room temperature.
Mechanical stability of scaffolds in a defect site was exam-
ined using mechanical push-in and push-out tests (𝑛 = 3) in
dry state in Sawbones©. Tapered cylindrical defectsmatching
the dimensions of the scaffolds were made using appropri-
ate drill bits in Sawbones© polyurethane foam (Sawbones
Europe AB, Malmo¨, Sweden). We used Sawbones© foam
with a density of 160 kg/m3 and a compressive modulus of
66MPa comparable to that of cancellous bone [34]. For push-
in/push-out tests, two types of experiments were designed:
blind-hole experiment to determine the push-in depth and
strength, and a through-hole experiment to observe the push-
out and interfacial strengths. Samples were inserted into the
created defects in Sawbones©, and the load required to push
them in/out (a ramp compressive extension of 1mm/min)
was monitored. The schematic illustration of each setup is
depicted in Figure 1. Based on the maximum load achieved
(from the load-displacement curves) and the area of scaffolds
in contact with Sawbones© (lateral surface area of a truncated
cone × 28% scaffold density) the interface strength between
the scaffolds and their surroundings was calculated.
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Figure 1: Schematics of blind and through holes experiments.
2.4. In Vitro Evaluation of Osteoinductivity. Viability and
osteoinductivity of sheep bone marrow mesenchymal stem
cells (BMMSCs) were evaluated on HAP coated and non-
coated Ti scaffolds. BMMSCs were isolated from sheep
bone marrow aspirate, expanded, and maintained in tissue
culture flasks containing Dulbecco’s modified eagles medium
(DMEM, Sigma-Aldrich, UK) supplemented with 10% fetal
calf serum (FCS, First Link, UK) and 100 Units/mL of Peni-
cillin and Streptomycin (P/S, Gibco, UK). Flasks were kept at
37∘Cwith 5%CO
2
and passaged when 80% of confluency was
reached. BMMSCswere characterised by demonstrating their
multipotency by differentiating them down the adipogenic,
chondrogenic, and osteogenic lineages.
Three sample groups were tested: coated Ti scaffold
(EM10), noncoatedTi scaffold, andThermanoxdiscs (Nalge
Nunc International, USA) as control (𝑛 = 3) in osteogenic
media.
Samples were sterilised by autoclaving and were then
seeded with 10,000 BMMSCs (passage 3) in a total volume
of 50 𝜇L basal cell culture media (DMEM, 10% FCS, 1% P/S).
After incubation for 1 hr at 37∘C with 5% CO
2
, 2-3mL of
osteogenic (basal media with 0.1 lM Dexamethasone, 500 lM
Ascorbic Acid, and 10mM b-glycerophosphate; all from
Sigma-Aldrich, UK) cell culture media was added to each
well. Media were changed every 3–5 days. Cell adhesion and
morphology (by DAPI and phalloidin stainings at days 7 and
21), proliferation (by AlamarBlue© activity at days 1, 14, and
28), and differentiation into the osteogenic lineage (Alizarin
Red staining at day 28) and cell colonisation andmorphology
(SEM at day 21) were studied for all groups and controls.
To assess cell adhesion and morphology, scaffolds were
fixed in 4% paraformaldehyde (PFA) for 30min, washed
twice with PBS, and permeabilised with 0.25% (v/v) Triton
X-100 in PBS for 30min. Samples were blockedwith 3% (w/v)
bovine serum albumin (BSA) in PBS for 30min and the actin
cytoskeleton was stained with Alexa Fluor 568 phalloidin
(Invitrogen; 1 : 200) for 1 h. Nuclei were stained with DAPI
(4,6-Diamidino-2-phenylindole, dihydrochloride, Sigma;
Fluoroshield) for 1min. Samples were mounted on glass
slides and cells were observed under a ZEISS ApoTome.2
Fluorescent Microscope (ZEISS, Germany).
AlamarBlue© was used to examine the proliferation of
cells on the samples. AlamarBlue© (AbD Serotec, UK) was
diluted in phenol free DMEM (Sigma, UK) to make a 10%
working solution. Samples were washed with PBS and incu-
bated with 1 mL of the working solution at 37∘C and 5% CO
2
.
After 4 h, 200𝜇L from each sample was loaded in triplicate
into a FluoroNunc white 96-well plate and fluorescence
wasmeasured at 530–560 nmexcitation and 590 nmemission
using amicroplate reader (Infinite 200 PRO, Tecan, Switzer-
land). Results were compared to those of an empty well
loaded with 1 mL of the working solution at the beginning
of the assay.
To assess late stage of osteogenesis, Alizarin Red staining
was performed quantitatively. At day 28, samples were fixed
with 4% (w/v) PFA for 30mins and then washed with PBS.
Samples were then incubated at room temperature with
Alizarin Red solution for 30mins, after which they were
washed with PBS and incubated with 200𝜇l 10% CPC in
10mM sodium phosphate (pH 7) for 15mins. Duplicates of
100 𝜇l of supernatant were transferred to a Nunc 96-well
plate, and the absorbance was measured with a microplate
reader (Infinite 200 PRO, Tecan, Switzerland) at 570 nm.
2.5. In Vivo Evaluations ofMechanical and Biological Fixation.
The bone tissue reaction to the porous Ti scaffold was
examined by animal tests using sheep condyle. Three sheep
(77–82 kg) were sedated by intravenous administration of
ketamine andmidazolam and sedation wasmaintained using
gaseous anaesthesia with 2.5% isoflurane. The sheep were
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Figure 2: SEM micrographs of HAp coated Ti scaffolds using biomimetic and electrochemical methods.
given Ceporex injections (active ingredient cephalexin), an
antibiotic, on days 0, 1, 2, and 3. Each sheep also had fentanyl
patches on days 1 and 3.
A collagen type-I–HAp scaffold was fabricated to act as
the control using a freeze-drying method. Briefly, lyophilised
collagen powder (Sigma-Aldrich, UK) was dispersed in
distilled water (pH 3.2 with acetic acid) using IKA blender
while HAp powder (Sigma-Aldrich, UK) was added to the
mix. The suspension was then casted into 3D printed resin
moulds, frozen, and freeze-dried.The noncoated Ti scaffolds,
as well as collagen-HAp scaffolds, were implanted into 10mm
(depth and upper diameter) bone defects in the left medial
condyle of sheep stifle joints and fixed by press-fit only. The
limbs were scanned radiologically and implanted titanium
scaffold and surrounding tissue were retrieved 12 weeks
after operation. Micro-computed tomography (micro-CT)
analysis was performed on samples using a Nikon XT H
225 with 110 kVP X-ray source and 112mA (resolution of
∼18–22𝜇m) in order to assess the new bone formed within
the titaniummatrix.Three-dimensional reconstructionswere
performed using Nikon CT Agent. Subsequent visualization
and analysis were performed in Bruker Software CTVOX and
CTAN. Subchondral bone repair was expressed as percentage
bone volume over the total volume (% BV/TV), while SEM
(JEOL JSM 5500 LV, at 10 kV) observations were used to
assess bone-scaffold interface.
2.6. Statistical Analysis. Statistical analyses were performed
using OriginPro 2015 (OriginLab). The data are presented as
means with standard deviation. One-way ANOVA and sub-
sequent post hoc Tukey tests were used to analyze differences
among the groups at significant level of 0.05.
3. Results and Discussion
3.1. Characterisation of HAp Coating. Porous Ti matrices
were coated with HAp using both a biomimetic and an
electrochemical method in order to select the most suitable
coating technique in terms of homogeneity. The morphology
of the HAp coatings, examined by SEM, is shown in Figure 2
and the compositions of the coatings, determined by EDX
analysis, are listed in Table 3.
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Table 3: Composition (Ca/P ratio) of different coatings obtained by
EDX; ∗ is used for further cell analyses.
Sample Ca/P ratio
EM6 1.84 ± 0.54
EM10∗ 1.85 ± 0.25
BM24 1.79 ± 0.21
BM48 1.85 ± 0.08
Table 4: Mechanical properties of porous Ti scaffold and its
mechanical fixation in Sawbones. Data are expressed as mean ±
standard deviation; ∗ shows significant difference at 𝑝 = 0.004.
Mechanical characteristics
Compressive strength 35MPa
Compressive modulus 73MPa
Young’s modulus 0.55MPa
Mechanical stability in vitro
Push-in depth 5.8mm
Push-in strength 5.67MPa (±1.54)∗
Push-out strength 1.44MPa (±1.14)∗
Interfacial shear strength 0.81MPa (±0.36)
From the EDX analysis, the molar ratio of calcium to
phosphorous (Ca/P) of HAp was 1.79–1.85 for both coating
methods showing a slightly calcium rich HAp compared to
stoichiometric HAp (Ca/P = 1.67). While the Ca/P ratio was
similar in all groups, it became apparent from SEM images
that the coating was more uniform in electrochemical depo-
sitionmethod, whereas the biomimetic procedure usually led
to nonuniform coating and blocking of the matrix pores.
Based on the uniformity criteria of the coatings, elec-
trochemical method with 10mA/cm2 setting (sample EM10)
was chosen for tests on cell adhesion proliferation and
mineralisation.
3.2. Mechanical Properties and In Vitro Fixation. The
mechanical properties of Ti scaffold were determined in
compression mode and are summarized in Table 4. It was
observed that the Ti scaffolds exhibited a compressive
strength of 35MPa and Young’s modulus of 0.55GPa, which
is within the range of trabecular bone (e.g., 1–100MPa for
compressive strength) [35, 36], and is comparable to values
(24MPa) achieved in a 75% porosity PM processed Ti matrix
[19]. In terms of bone, mid-range values for the modulus of
trabecular bone are 90–400MPa. The compressive modulus
of our Ti scaffold reached 73MPa, which is slightly lower than
the lower range of native bone modulus. However, it must
be noted that the values of native bone vary considerably
across different locations and patients. An example is the
compressionmodulus of human cancellous bone obtained by
Martens et al. (1983), where superior-anterior femoral head
showed a modulus of 900 ± 714MPa, while the anterior-
posterior showed a modulus of only 12 ± 6MPa and medial-
lateral a modulus of 63 ± 7MPa [37].
To evaluate the mechanical stability of scaffolds when
placed in a defect, the push-in, push-out, and interfacial
strengths aswell as the push-in depthwere assessed, and these
are reported inTable 4.Mechanical stability can be influenced
by interlocking of the newly formed bone, the macroscopic
design of the implant, and its stiffness and interface stress, as
well as the interface friction and the bone-implant gap size
[38]. Because there is no contribution from ingrownbone, the
stability of scaffold in vitro solely relies on the macroscopic
design of scaffold, friction coefficient, and gap size between
bone and scaffold.
In fact, friction influences the mechanical stability of an
implant and its relative migration in the bone and affect
seating of the implant in the bone [39].The friction coefficient
values obtained in Sawbones in dry state are usually lower
than those in the lubricated human bone resembling the
actual implant condition.
We observed that the achieved push-in and push-out
strengths were in fact greatly affected by the degree to
which the scaffolds were fitted in the defects. Even slightest
mismatch between geometries could lead to a significant
decrease in the interface strength.
The push-in strength was determined to be significantly
higher than the push-out strength (𝑝 = 0.004). It is believed
that the tapered design of the scaffold contributed the higher
values of push-in strength compared to push-out strength.
In a study on bone-implant interface strength and
osseointegration in rats, the ex vivo interface shear strength of
a Ti alloy implant after 4weekswas reported to be in the range
of 0.57–1.50MPa [40]. The ultimate interface shear strength
of porous Ti scaffold in our study is 0.81MPa, demonstrating
that the scaffold mechanical fixation in vitro is comparable to
that of a Ti alloy implant in vivo and would fulfil one of the
key requirements, that is, mechanical stability to be retained
in the affected area, for bone scaffolds.
3.3. Evaluation of Osteoinductivity In Vitro. All scaffolds
(HAp coated and noncoated) allowed for cell attachment
and viability throughout 28-day culture period. Presence of
metabolically active cells and their proliferation, as deter-
mined by AlamarBlue analysis, indicated an increase in
the number of cells attached on the scaffolds during the
culture period (Figure 3). AlamarBlue activity was higher
on day 1 on noncoated scaffolds compared to HAp coated
scaffolds, showing higher cell attachment to noncoated sam-
ples. Metabolic activity peaked at day 14, again significantly
higher on noncoated scaffolds, whichmay indicate higher cell
division on these samples. The decrease in metabolic activity
after day 14may demonstrate stem cell differentiation towards
an osteogenic lineage, which is confirmed by Alizarin Red
quantification results on day 28.
Immunofluorescence staining for actin cytoskeleton
showed a well-developed cytoskeleton suggesting cells could
adopt a flattened and spread morphology on noncoated
scaffolds, while DAPI staining indicated the presence of cells
as evidenced by staining of their nuclei covering the entire
scaffold surface (Figure 4). Scanning electron microscopy
further confirmed the attachment and proliferation of the
seeded cells on both coated and noncoated scaffolds. Spindle-
like cells, with cell –cell contact were observed attached to the
surface of the HAp coated and noncoated titanium scaffolds
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Figure 3: Biocompatibility and osteoinductivity of porous Ti
scaffolds. AlamarBlue absorbance of BMMSCs seeded on HAp
coated noncoated scaffolds over 28 days; Alizarin Red absorbance
normalized to noncoated samples at day 28. ∗ shows significantly
higher value compared to other samples (𝑝 < 0.05).
(Figure 5). Osteoblastic like cells and mineral nodules were
observed on and within the core of the scaffolds by day 21 of
the culture.
Alizarin Red staining was used to determine late-stage
osteoblastic differentiation. Alizarin Red quantification over
21 days of culture period confirmed osteoblastic differentia-
tion of the seeded cells on both coated and HAp noncoated
scaffolds (Figure 3). Noncoated samples indicated higher
Alizarin Red absorbance; however this may be associated
with the poor release of the stain from the HA coating during
the quantification process. By normalizing the concentrations
to that of noncoated samples bothHAp coated and noncoated
scaffolds indicated similar levels of differentiation (Figure 3).
3.4. Bone Formation and Ingrowth. For the clinical deter-
mination of the bone ingrowth inside the scaffold recent
advances in the 𝜇CT imaging have shown sufficient reso-
lution for the accurate identification of the bone ingrowth
within the metallic porous structure [23]. A 3D volume
of bone-scaffold was reconstructed from 𝜇CT images and
sagittal, coronal, and transverse sections are presented in
Figure 6, showing bone trabeculae inside the scaffold porous
structure. We observed areas of incomplete bone regen-
eration below the scaffold; the void is speculated to be
generated during the surgery with the drill, which has been
unable to heal. The amount of bone ingrowth in scaffold
and control groups was quantified using the principles for
bone histomorphometry and is reported in Figure 6. We
observed that the BV/TV was significantly higher (𝑝 =
0.01) in the scaffold group compared to the control group,
which consisted of a collagen-HApmatrix.The bone-implant
contact was calculated to be 70%, and the interface between
the Ti struts and the regenerated bone, demonstrating a very
close contact between the two, is shown by SEM images in
Figure 7, which further confirms integration of Ti scaffold
and the newly formed bone.
We speculate that the significant increase in bone regen-
eration in the defects treated with porous titanium scaf-
folds compared to collagen-HAp scaffold may be related
to the scaffold structure and its mechanical properties,
as it possesses an interconnected porous structure and
mechanical properties in range of trabecular bone. The
mechanism of osteoinduction in porous biomaterials and
its biological effects are still largely unknown. However, it
has been argued that biomaterials must meet very specific
requirements in terms of macrostructure (e.g., geometry and
porosity), microstructure (e.g., microporosity and surface
roughness), and chemical composition (calcification ability)
in order to be osteoinductive [29, 41]. For example, it
has been previously shown that porous Ti containing no
calcium phosphate can become osteoinductive when it has
a complex interconnecting porous structure and bioactive
surfaces activated by simple chemical and thermal treatments
[28, 29]. However, in this study, we have shown that surface
modification and/or HAp coating might not be required
for osteoinduction of porous titanium. The developed 3D
printed Ti scaffold possess a rough surface (microstructure),
an interconnected structure of pores with over 70% poros-
ity, and mechanical properties in range of trabecular bone
(macro- and microstructure), but they do not contain any
source of calcium phosphate. Inmaterials containing calcium
phosphate, the Ca2+, PO3−
4
, and HPO2−
4
are liberated from
the surface into the surroundingwhichmay increase the local
supersaturation of the biologic fluid, causing precipitation
of carbonated apatite that incorporates calcium, phosphate,
and other ions [42]. The dissolution part of this process is
missing in the materials that initially do not contain calcium
phosphate; however, their physicochemical properties are
such that they provide nucleation sites for the deposition of a
biological apatite layer [41]. It is plausible that similar events
occurred in the developed Ti scaffold providing nucleation
sites for calcification and bone formation.
4. Conclusions
We have developed a highly porous (72%) Ti scaffold for
bone tissue engineering using additive manufacturing (selec-
tive laser sintering) technique. The mechanical properties,
8 International Journal of Biomaterials
Day 7 Day 21
Figure 4: Cell-scaffold interaction; immunostaining of cells on porous noncoated Ti scaffold shows cell nuclei (DAPI, blue) and cytoskeleton
(phalloidin, green) at days 7 and 21.
Noncoated Ti HAp coated Ti
Figure 5: Cell morphology and osteogenesis on coated and noncoated Ti scaffolds; noncoated: flat cuboidal osteoblastic cells and mineral
nodules (red arrow) on the scaffold peaks; coated: spindle-like cells and round mineral nodules (red arrow) attached to HAp coated scaffold
surface.
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Figure 6: Bone ingrowth into Ti matrix. 𝜇CT images show bone formation within the Ti scaffold; ∗ shows significantly higher bone volume
formation in the scaffold compared to control (𝑝 = 0.01).
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Figure 7: Bone-scaffold interface; SEM images show bone (B) in contact with the metal (M).
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including compressive strength and stiffness of the produced
scaffold, were in range of human trabecular bone, and they
showed a stable mechanical fixation in vitro, comparable to
fixations observed after 4weeks of bone ingrowth.We showed
that both HAp coated and noncoated scaffolds promote
osteogenesis in vitro and HAp coating did not produce
a significant increase in late osteogenesis. Bone formation
and ingrowth in sheep stifle joints confirmed that the Ti
scaffolds—as produced and without any coating—exhibited
an intrinsic capacity for bone formation and osteoinduction.
Therefore, these scaffolds have the potential to be used for
tissue engineering of large bone defects and nonunions.
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